The Peter Doherty Institute for Infection and Immunity is a research institute located in Melbourne, Australia. The Doherty Institute is named after the name of Laureate Professor Peter C. Doherty (Nobel prize winner in 1996). This institute is a joint venture between The University of Melbourne and The Royal Melbourne Hospital.[1][2]

COVID-19 response

Modelling Report for National Cabinet

Doherty Institute has advised the Australian government for the transition to nation reopening based upon the vaccination progress in the modelling report. This 4-phase transition plan depends upon the percentage (70%/*80%) of the fully vaccinated eligible population(16 years or older).[3][4][5][6] In February 2022, the Doherty Institute advised against periodic six-month boosters.[7]

References

  1. ^ a b "The Peter Doherty Institute for Infection and Immunity" (PDF). Archived (PDF) from the original on 6 July 2017. Retrieved 21 August 2021.
  2. ^ "The Peter Doherty Institute for Infection and Immunity - About | Doherty Website". www.doherty.edu.au.
  3. ^ "Doherty Institute Modelling Report for National Cabinet". 3 August 2021.
  4. ^ "Doherty Institute Modelling Report to advise on the National Plan to transition Australia's National COVID Response". Australian Government Department of Health. 3 August 2021.
  5. ^ "Doherty modelling report for National Cabinet 30 July 2021". Peter Doherty Institute for Infection and Immunity. 3 August 2021 – via apo.org.au.
  6. ^ "Economic Impact Analysis: National Plan to Transition to Australia's National COVID 19 Response | Treasury.gov.au". treasury.gov.au.
  7. ^ "Boosters every six months not a viable strategy, says Doherty chief". Australian Financial Review. 6 February 2022. Retrieved 19 April 2022.

External links